Metagenomi inc MGX.US 總覽分析

MGX 投資分析

MGX 近期報酬表現

與 MGX 同產業的標的表現

• QURE Uniqure nv

  價值 2 分趨勢 4 分波段 4 分籌碼 3 分股利 1 分

  查看更多
• OSTX Os therapies inc
• IPHA Innate pharma sa (adr)
• CRDF Cardiff oncology inc
• CPIX Cumberland pharmaceuticals incorporation
• CVM Cel-sci corp
• SABS Sab biotherapeutics inc
• MXCT Maxcyte inc
• XFOR X4 pharmaceuticals inc
• ABSI Absci corp

MGX 公司資訊

Metagenomi, Inc. is a precision genetic medicine company. The Company is focused on developing curative therapeutics for patients using its comprehensive metagenomics derived toolbox. Its diverse and modular genome editing toolbox is designed to precisely target any site in the human genome. Its comprehensive genome editing toolbox includes programmable nucleases, base editors, and RNA and DNA-mediated integration systems, including prime editing systems and clustered regularly interspaced short palindromic repeat (CRISPR)-associated transposases (CASTs). It has also developed a modular toolbox of genome editing systems that will allow it to interact with the human genome in a site-specific manner, where each tool can be matched to specific disease targets. The Company uses artificial intelligence and its metagenomics platform to develop curative genetic medicines.